Components:

Paracetamol, Propyphenazone, Acetaminophen, Caffeine

Medically reviewed by Oliinyk Elizabeth Ivanovna, PharmD. Last updated on 26.06.2023

Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!

Top 20 medicines with the same components:

Dolostop Neo-Optalidon

Name of the medicinal product

Neo-Optalidon

Therapeutic indications

An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, Acetaminophen (Neo-Optalidon) or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.

Headache, fever, toothache, neuralgia, dysmenorrhea, fatigue due to common colds & other viral infections.

Contraindications

Kidney & liver dysfunction, haemolytic anemia, porphyria, acute hepatitis.

Interaction with other medicinal products and other forms of interaction

Acetaminophen (Neo-Optalidon) is metabolized (eliminated by conversion to other chemicals) by the liver. Therefore drugs that increase the action of liver enzymes that metabolize Acetaminophen (Neo-Optalidon) [for example, carbamazepine (Tegretol), isoniazid (INH, Nydrazid, Laniazid), rifampin (Rifamate, Rifadin, Rimactane)] reduce the levels of Acetaminophen (Neo-Optalidon) and may decrease the action of Acetaminophen (Neo-Optalidon). Doses of Acetaminophen (Neo-Optalidon) greater than the recommended doses are toxic to the liver and may result in severe liver damage. The potential for Acetaminophen (Neo-Optalidon) to harm the liver is increased when it is combined with alcohol or drugs that also harm the liver.

Cholestyramine (Questran) reduces the effect of Acetaminophen (Neo-Optalidon) by decreasing its absorption into the body from the intestine. Therefore, Acetaminophen (Neo-Optalidon) should be administered 3 to 4 hours after cholestyramine or one hour before cholestyramine.

Acetaminophen (Neo-Optalidon) doses greater than 2275 mg per day may increase the blood thinning effect of warfarin (Coumadin) by an unknown mechanism. Therefore, prolonged administration or large doses of Acetaminophen (Neo-Optalidon) should be avoided during warfarin therapy

Undesirable effects

Hypersensitivity reactions; nephrotoxicity. Nausea, drowsiness, coma and convulsions on large doses.

Available in countries

A-Z index:

A B C D E F G H I J K L M N O P Q R S T U V Y Z